SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Malin JL, Schuster MA, Kahn KA, Brook RH. Quality of breast cancer care: what do we know? J Clin Oncol. 2002; 20: 43814393.
  • 2
    Hill D, Jamrozik K, White V, et al. Surgical management of breast cancer in Australia in 1995. Sydney: National Health and Medical Research Council National Breast Cancer Centre, 1999.
  • 3
    Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment and survival among breast cancer patients under age 35. Cancer. 2003; 97: 134147.
  • 4
    Mandelblatt JS, Hadley J, Kerner JF, et al. Patterns of breast cancer treatment in older women: patient preference and clinical and physical influences. Cancer. 2000; 89: 561573.
  • 5
    Mandelblatt JS, Kerner JF, Hadley J, et al. Variation in breast cancer treatment in older Medicare beneficiaries: is it black or white. Cancer. 2002; 95: 14011414.
  • 6
    Tyldesley S, Boyd C, Shulze K, Walker H, Mackillop WJ. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys. 2001; 49: 973985.
  • 7
    NHMRC National Breast Cancer Centre. Clinical practice guidelines for the management of ductal cancer in situ. Consultation draft. Sydney: National Health and Medical Research Council, 2001.
  • 8
    NHMRC National Breast Cancer Centre. Clinical practice guidelines for the management of advanced breast cancer. Sydney: National Health and Medical Research Council National Breast Cancer Center, 2001.
  • 9
    NHMRC National Breast Cancer Centre. Clinical practice guidelines for the management of early breast cancer. Second stage consultation draft. Sydney: National Health and Medical Research Council National Breast Cancer Center, 2001.
  • 10
    National Breast Cancer Center Radiation Oncology Advisory Group. NHMRC National Breast Cancer Centre report of the effectiveness of postmastectomy radiotherapy and risk factors for local recurrence in early breast cancer. Sydney: National Health and Medical Research Council National Breast Cancer Centre, 1999.
  • 11
    National Cancer Institute. PDQ cancer information summaries: treatment of breast cancer [monograph online]. Available from URL: http://www.nci.nih.gov/cancerinfo/pdq/treatment/breast/healthprofessional [accessed Feb 21, 2003].
  • 12
    Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001; 19: 15391569.
  • 13
    Hillner BE, Ingle JN, Berenson JR, et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. J Clin Oncol. 2000; 18: 13781391.
  • 14
    National Comprehensive Cancer Network. National practice guidelines in oncology—breast cancer. Version 2 [monograph online]. Available from URL: http://www.nccn.org/physician_gls/f_guidelines.html [accessed Feb 21, 2003].
  • 15
    Simpson JR, Mendenhall WM, Schupak KD, et al. ACR appropriateness criteria for follow-up and retreatment of brain metastases. Radiology. 2000; 215: 11291135.
  • 16
    Loeffler JS, Bloomer WD, Buckley JA, et al. ACR appropriateness criteria for solitary brain metastasis. Radiology. 2000; 215: 11111120.
  • 17
    National Institutes of Health Consensus Development Panel. Adjuvant therapy for breast cancer [monograph online]. Available from URL: http://www.consensus.nih.gov/cons/114/114_statement.htm. [accessed Feb 21, 2003].
  • 18
    Cancer Care Ontario Practice Guideline Initiative. Management of ductal cancer in situ of the breast (Practice Guideline Report No. 1-10) [monograph online]. Available from URL: http://www.cancercare.on.ca/pdf/full1_10.pdf [accessed Feb 21, 2003].
  • 19
    Cancer Care Ontario Practice Guideline Initiative. Breast irradiation in women with early stage invasive breast cancer following breast conserving surgery (Practice Guideline Report No. 1-2) [monograph online]. Available from URL: http://www.cancercare.on.ca/pdf/full1_2.pdf [accessed Feb 21, 2003].
  • 20
    Cancer Care Ontario Practice Guideline Initiative. Use of bisphosphonates in patients with bone metastases from breast cancer (Practice Guideline Report No. 1-11, Version 2) [monograph online]. Available from URL: http://www.cancercare.on.ca/pdf/pebc1_11f/pdf [accessed Feb 21, 2003].
  • 21
    British Columbia Cancer Agency. Cancer management guidelines—breast cancer [monograph online]. Available from URL: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Breast/start.htm [accessed Feb 21, 2003].
  • 22
    The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer. A Canadian consensus document [monograph online]. Available from URL: http://www.cmaj.ca/cgi/content/full/158/3/DC1physicians [accessed Feb 21, 2003].
  • 23
    Scottish Intercollegiate Guidelines Network. Breast cancer in women. A national clinical guideline [monograph online]. Available from URL: http://www.sign.ac.uk/guidelines/fulltext/29/index.html [accessed November 9, 2001].
  • 24
    Scottish Intercollegiate Guidelines Network. Control of pain in patients with cancer. A national clinical guideline [monograph online]. Available from URL: http://www.sign.ac.uk/guidelines/fulltext/44/index.html [accessed Feb 21, 2003].
  • 25
    Royal College of Radiologists Clinical Oncology Information Network. Guidelines on the non-surgical management of breast cancer [monograph online]. Available from URL: http://www.rcr.ac.uk/breast.txt [accessed Feb 21, 2003].
  • 26
    Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia 1998. Canberra: Australian Institute of Health and Welfare, 2001.
  • 27
    Kricker A, Smoothy V, Armstrong B. Ductal cancer in situ in New South Wales women in 1995 to 1997. Sydney: National Breast Cancer Centre, 2000.
  • 28
    Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal cancer in situ: a meta-analysis. Cancer. 1999; 85: 616628.
  • 29
    Wilking N, Rutqvist LE, Carstensen J, Mattsson A, Skoog L. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol. 1992; 31: 2935.
  • 30
    Morrow M, Bucci C, Rademaker A. Medical contraindications are not a major factor in the underutilization of breast conserving therapy. J Am Coll Surg. 1998; 186: 269274.
  • 31
    Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987; 55: 6166.
  • 32
    Leone BA, Romero A, Rabinovich MG, et al. Stage IV breast cancer: clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis. Am J Clin Oncol. 1988; 11: 618622.
  • 33
    South Australian Cancer Registry. Epidemiology of cancer in South Australia. September 2000 (Cancer Series No. 22). Adelaide: South Australian Cancer Registry, 2000.
  • 34
    Statewide Services Development Branch. NSW radiotherapy management information system report 2000. Sydney: New South Wales Health Department, 2001.
  • 35
    National Cancer Institute. SEER cancer incidence public-use database, 1973–1999. Bethesda: Department of Health and Human Services, 2002.
  • 36
    American College of Surgeons. National cancer database [monograph online]. Available from URL: http://www.facs.org.dept/cancer/ncdb/whatsncdb.html
  • 37
    The Western Areas Breast Group. Breast cancer patterns of care in the Greater Western region of Sydney in 1992. NSW Breast Cancer Institute. Sydney: New South Wales Department of Health, 1997.
  • 38
    Hill DJ, White VM, Giles GG, Collins JP, Kitchen PR. Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust. 1994; 161: 110118.
  • 39
    Northern and Yorkshire Cancer Registry and Information Service. Quick data V2.1 [monograph online]. Available from URL: http://www.nycris.org.uk
  • 40
    Pivot X, Asmar L, Hortobagyi GN, et al. A retrospective study of first indicators of breast cancer recurrence. Oncology. 2000; 58: 185190.
  • 41
    Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat. 2000; 59: 271278.
  • 42
    Colleoni M, O'Neill A, Goldhirsch A, et al. Identifying breast cancer patients at high risk for bone metastases. J Clin Oncol. 2000; 18: 39253935.
  • 43
    Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997; 337: 956962.
  • 44
    Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997; 337: 949955.
  • 45
    Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999; 353: 16411648.
  • 46
    Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys. 2002; 53: 12401253.
  • 47
    Australian Health Technology Advisory Committee. Beam and isotope radiotherapy. Canberra: National Health and Medical Research Council, 1996.
  • 48
    Wigg DR, Morgan GW. Radiation oncology in Australia: workforce, workloads and equipment 1986–1999. Australas Radiol. 2001; 45: 146169.